A	0	1	O
novel	2	7	O
integrin	8	16	B-Gene_or_gene_product
alpha5beta1	17	28	I-Gene_or_gene_product
antagonistic	29	41	O
peptide	42	49	O
,	49	50	O
A5	51	53	B-Gene_or_gene_product
-	53	54	I-Gene_or_gene_product
1	54	55	I-Gene_or_gene_product
,	55	56	O
screened	57	65	O
by	66	68	O
Protein	69	76	O
Chip	77	81	O
system	82	88	O
as	89	91	O
a	92	93	O
potent	94	100	O
angiogenesis	101	113	O
inhibitor	114	123	O
.	123	124	O

Integrin	126	134	B-Gene_or_gene_product
alpha5beta1	135	146	I-Gene_or_gene_product
immobilized	147	158	O
on	159	161	O
a	162	163	O
ProteoChip	164	174	O
was	175	178	O
used	179	183	O
to	184	186	O
screen	187	193	O
new	194	197	O
antagonistic	198	210	O
peptides	211	219	O
from	220	224	O
multiple	225	233	O
hexapeptide	234	245	O
sub	246	249	O
-	249	250	O
libraries	250	259	O
of	260	262	O
the	263	266	O
positional	267	277	O
scanning	278	286	O
synthetic	287	296	O
peptide	297	304	O
combinatorial	305	318	O
library	319	326	O
(	327	328	O
PS	328	330	O
-	330	331	O
SPCL	331	335	O
)	335	336	O
.	336	337	O

The	338	341	O
integrin	342	350	B-Gene_or_gene_product
alpha5beta1	351	362	I-Gene_or_gene_product
-	362	363	O
Fibronectin	363	374	B-Gene_or_gene_product
interaction	375	386	O
was	387	390	O
demonstrated	391	403	O
on	404	406	O
the	407	410	O
chip	411	415	O
.	415	416	O

A	417	418	O
novel	419	424	O
peptide	425	432	O
ligand	433	439	O
,	439	440	O
A5	441	443	B-Gene_or_gene_product
-	443	444	I-Gene_or_gene_product
1	444	445	I-Gene_or_gene_product
(	446	447	O
VILVLF	447	453	B-Gene_or_gene_product
)	453	454	O
,	454	455	O
with	456	460	O
high	461	465	O
affinity	466	474	O
to	475	477	O
integrin	478	486	B-Gene_or_gene_product
alpha5beta1	487	498	I-Gene_or_gene_product
was	499	502	O
identified	503	513	O
from	514	518	O
the	519	522	O
hexapeptide	523	534	O
libraries	535	544	O
with	545	549	O
this	550	554	O
chip	555	559	O
-	559	560	O
based	560	565	O
screening	566	575	O
method	576	582	O
on	583	585	O
the	586	589	O
basis	590	595	O
of	596	598	O
a	599	600	O
competitive	601	612	O
inhibition	613	623	O
assay	624	629	O
.	629	630	O

A5	631	633	B-Gene_or_gene_product
-	633	634	I-Gene_or_gene_product
1	634	635	I-Gene_or_gene_product
inhibits	636	644	O
the	645	648	O
integrin	649	657	B-Gene_or_gene_product
-	657	658	O
fibronectin	658	669	B-Gene_or_gene_product
interaction	670	681	O
in	682	684	O
a	685	686	O
dose	687	691	O
-	691	692	O
dependent	692	701	O
manner	702	708	O
(	709	710	O
IC	710	712	O
(	712	713	O
50	713	715	O
)	715	716	O
;	716	717	O
1	718	719	O
.	719	720	O
56	720	722	O
+	722	723	O
/	723	724	O
-	724	725	O
0	725	726	O
.	726	727	O
28	727	729	O
microM	730	736	O
.	736	737	O

In	738	740	O
addition	741	749	O
,	749	750	O
it	751	753	O
inhibits	754	762	O
human	763	768	B-Cell
umbilical	769	778	I-Cell
vein	779	783	I-Cell
endothelial	784	795	I-Cell
cell	796	800	I-Cell
proliferation	801	814	O
,	814	815	O
migration	816	825	O
,	825	826	O
adhesion	827	835	O
,	835	836	O
tubular	837	844	B-Multi-tissue_structure
network	845	852	I-Multi-tissue_structure
formation	853	862	O
,	862	863	O
and	864	867	O
bFGF	868	872	B-Gene_or_gene_product
-	872	873	O
induced	873	880	O
neovascularization	881	899	O
in	900	902	O
a	903	904	O
chick	905	910	B-Organism
chorioallantoic	911	926	B-Multi-tissue_structure
membrane	927	935	I-Multi-tissue_structure
.	935	936	O

These	937	942	O
results	943	950	O
suggest	951	958	O
that	959	963	O
A5	964	966	B-Gene_or_gene_product
-	966	967	I-Gene_or_gene_product
1	967	968	I-Gene_or_gene_product
will	969	973	O
be	974	976	O
a	977	978	O
potent	979	985	O
inhibitor	986	995	O
of	996	998	O
neovascularization	999	1017	O
.	1017	1018	O

